Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

Janux Therapeutics Q4 EPS $(0.39) Beats $(0.49) Estimate, Sales $2.85M Beat $790.00K Estimate

By Michael Horton
March 10, 5:02 PM
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.49) by 20.41 percent. This is a 18.18 percent decrease over losses of $(0.33) per share

JANX

Read More
1 minute read
  • Earnings
  • Guidance
  • News

Oracle Says Expects Q4 Total Cloud Growth Excluding Cerner Of 30% In Constant Currency

By Michael Horton
March 9, 6:22 PM
-Reuters

ORCL

Read More
1 minute read
  • Guidance
  • News

Oracle Says Expect To Continue Winning Big Cloud Deals That Are Subscription Driven Vs License Driven

By Michael Horton
March 9, 6:20 PM
-Reuters

ORCL

Read More
1 minute read
  • Earnings
  • News

Caribou Biosciences Q4 EPS $(0.44) Beats $(0.46) Estimate, Sales $3.69M Beat $3.07M Estimate

By Michael Horton
March 9, 6:10 PM
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.46) by 4.35 percent. This is a 41.94 percent decrease over losses of $(0.31) per share

CRBU

Read More
1 minute read
  • News
  • Offerings

Miromatrix Medical Files For Offering Of Up To 6.25M Shares Of Common Stock

By Michael Horton
March 9, 6:02 PM
-SEC Filing

MIRO

Read More
1 minute read
  • Earnings
  • News

Wheaton Precious Metals Q4 Adj. EPS $0.23 Misses $0.25 Estimate, Sales $236.05M Miss $255.50M Estimate

By Michael Horton
March 9, 6:01 PM
Wheaton Precious Metals (NYSE:WPM) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.25 by 8.4 percent. This is a 21.84 percent decrease over earnings of $0.29 per share

WPM

Read More
1 minute read
  • General
  • Social Media
  • Trading Ideas

Top 15 Trending Stocks On WallStreetBets As Of Thursday, Mar. 9, 2023 (Via Swaggy Stocks)

By Michael Horton
March 9, 5:54 PM
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment   Nvidia (NVDA) Tesla (TSLA) Apple (AAPL) C3.ai (AI) JP Morgan Chase (JPM) Advanced Micro Devices (AMD) Invesco QQQ Trust

AAPL

Read More
1 minute read
  • Earnings
  • News

Guild Holdings Q4 Sales $134.30M Miss $154.92M Estimate

By Michael Horton
March 9, 5:23 PM
Guild Holdings (NYSE:GHLD) reported quarterly sales of $134.30 million which missed the analyst consensus estimate of $154.92 million by 13.31 percent. This is a 60.85 percent decrease over sales of $343.06 million the

GHLD

Read More
1 minute read
  • Earnings
  • News

Smith & Wesson Brands Q3 Adj. EPS $0.25 Beats $0.22 Estimate, Sales $129.04M Beat $125.35M Estimate

By Michael Horton
March 9, 5:21 PM
Smith & Wesson Brands (NASDAQ:SWBI) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.22 by 13.64 percent. This is a 63.77 percent decrease over earnings of $0.69 per share

SWBI

Read More
1 minute read
  • Earnings
  • News

Pliant Therapeutics Q4 EPS $(0.72) Misses $(0.70) Estimate, Sales $1.97M Beat $1.43M Estimate

By Michael Horton
March 9, 5:15 PM
Pliant Therapeutics (NASDAQ:PLRX) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.70) by 2.86 percent. This is a 5.88 percent decrease over losses of $(0.68) per share

PLRX

Posts pagination

Previous 1 … 8 9 10 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service